SEC Form 4 · accession 0001553878-16-000038
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David-Alexandre C Gros
Officer — SVP, Chief Business Officer
Period of report
Feb 22, 2016
Accepted (ET)
Feb 24, 2016 · 6:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 22, 2016 | P | 100 | $62.74 | A | 100 | D | |
| Common Stock | Feb 22, 2016 | P | 900 | $62.75 | A | 1,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The open market purchase of Common Stock reported on this Form 4 was made by the reporting person on February 22, 2016.